Phoreus Biotechnology, Inc. is a cutting-edge provider of proprietary technology platforms revolutionizing precision drug delivery for the next generation of genetic vaccines and therapeutics. Their Branched Amphipathic Peptide Capsules (BAPC) and Corralling Amphipathic Peptide Colloids (CAPC) offer increased efficacy in creating and delivering novel vaccines, cancer therapies, small molecules, and biopesticides for improved human, animal, plant, and environmental health worldwide.
Devoted to enhancing human, environmental, and animal health, Phoreus technology aims to improve the thermostability of delicate nucleic acid components, potentially eliminating the need for costly cold chain storage for revolutionary new vaccines and therapeutics. Their nanocarriers are non-toxic, self-assembling, peptide-based nanoparticles that provide stable mRNA at room temperature, making them ideal for genetic vaccines, cancer therapeutics, and genetic editing tools.
Generated from the website